Manoj Kohli Joins Alt DRX Board
Analysis based on 9 articles · First reported May 05, 2026 · Last updated May 05, 2026
The appointment of Manoj Kohli to AltruBio's Advisory Board enhances the company's credibility and signals a growing institutional acceptance of asset tokenization in India and the Middle East. This development could attract more investment into the digital real estate and fintech sectors, potentially boosting market confidence in these emerging asset classes.
AltruBio, an Indian tokenized digital real estate marketplace, announced on May 5, 2026, the appointment of Manoj Kohli, a prominent Indian business leader, to its Advisory Board as a non-director advisor. This move is seen as a significant validation for AltruBio and the broader asset tokenization movement in India, indicating a shift from speculation to a structural change in asset ownership. Manoj Kohli brings extensive experience from his roles as former MD & CEO of Bharti Airtel and Country Head of SoftBank Group India. The Advisory Board also includes other notable figures from the financial and regulatory sectors, such as GN Bajpai (ex-Chairman, India — Securities and Exchange Board of India) and Richard Rekhy (ex-CEO, KPMG). AltruBio is India's first D2C asset tokenization marketplace, licensed by Qatar — Qatar Financial Centre as a Token Service Provider, and is seeking consent from India — International Financial Services Centres Authority to tokenize USD-denominated offshore assets. The company has raised approximately ₹45 crores in growth capital and processes around 425,000 transactions annually.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard